MRAI logo

Marpai (MRAI)

Profile

Full Name

Marpai, Inc.

Ticker Symbol

MRAI

Exchange

NASDAQ

Sector

Healthcare

Industry

Healthcare Plans

Country

United States

IPO

October 27, 2021

Indexes

Not included

Website

http://www.marpaihealth.com

Employees

117

Key Details

Price

$0.95(-7.66%)

Market cap

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$37.16M(+52.64% YoY)

Annual EPS

-$4.14(+20.84% YoY)

PE ratio

-

Next earnings date

N/A

Next ex-dividend date

N/A

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Current Price

$0.95
MRAI price is $0.95

30-Day Relative Volume

0.49
MRAI 30-day relative volume is 0.49

Price Performance

Price Most recent change

-7.66%
MRAI price was down -7.66% on Apr 16, 2025

Price YTD change

+0.12%
MRAI price is up +0.12% since January 1st

Price 1-year change

-56.47%
MRAI price is down -56.47% year-on-year

Price 3-year change

-82.58%
MRAI price is down -82.58% over the past 3 years

Price Range

Price All-time high

$25.24
MRAI price is currently -96.23% below its historical high of $25.24

Price 3-year low

$0.33
MRAI price is currently +188.21% above its 3-year low

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Market cap

$9.80M
MRAI market capitalization is $9.80 million

Market cap 3-year change

-64.62%
MRAI market capitalization is down -64.62% over the past 3 years

Market cap All-time high

$107.89M
MRAI market capitalization is currently -90.91% below its historical high of $107.89 million

Market cap sector rank

19.98%
MRAI market capitalization is higher than 19.98% of companies in Healthcare sector

Shares Outstanding

Shares Outstanding 1-Year Change

0%
MRAI {parameterFullLabel} has remained unchanged year-on-year

Shares Outstanding 3-Year Change

+103.12%
MRAI shares outstanding is up +103.12% over the past 3 years

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Beta

0.85
MRAI beta is 0.85

200-day SMA

$0.85
MRAI price is currently +12.00% above its 200-day simple moving average

50-day SMA

$0.95
MRAI price is currently +0.20% above its 50-day simple moving average

RSI

49.13
MRAI 14-day relative strength index is 49.13

Volume

0.49
MRAI 30-day relative volume is 0.49

ATR

$0.08
MRAI average true range is $0.08

10-day Historical Volatility

149.34%
MRAI 10-day historical volatility is 149.34%

Dividend

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Revenue

$37.16M
MRAI annual revenue is $37.16 million

Revenue Analysts estimate

$33.73M
MRAI annual revenue is currently +10.15% higher than the consensus analysts' forecast

Revenue 1-year change

+52.64%
MRAI annual revenue is up +52.64% year-on-year

Revenue Sector rank

43.13%
MRAI annual revenue is higher than 43.13% of companies in Healthcare sector

EPS

EPS

-$4.14
MRAI annual earnings per share is -$4.14

EPS Analysts estimate

-
MRAI annual earnings per share consensus analysts' forecast is unknown

EPS 1-year change

+20.84%
MRAI annual earnings per share is up +20.84% year-on-year

EPS Sector rank

22.12%
MRAI annual earnings per share is higher than 22.12% of companies in Healthcare sector

Profit

Gross profit

$12.92M
MRAI annual gross profit is $12.92 million

Gross margin

34.76%
MRAI annual gross profit margin is 34.76%

Operating profit

-$26.37M
MRAI annual operating income is -$26.37 million

Operating margin

-70.98%
MRAI annual operating profit margin is -70.98%

Net income

-$28.75M
MRAI annual net profit is -$28.75 million

Net margin

-77.38%
MRAI annual net profit margin is -77.38%

Expenses

Total expenses

$63.53M
MRAI annual total expenses is $63.53 million

Operating expenses

$39.29M
MRAI annual total operating expenses is $39.29 million

Cost of goods sold

$24.24M
MRAI annual cost of goods sold is $24.24 million

Selling, general & administrative expenses

$25.77M
MRAI annual SGA is $25.77 million

Depreciation and amortization

$5.40M
MRAI annual depreciation & amortization is $5.40 million

Interest expense

$1.53M
MRAI annual interest expense is $1.53 million

Income tax

-$290.10K
MRAI annual income tax is -$290.10 thousand

EBIT & EBITDA

EBIT

-$27.51M
MRAI annual earnings before interest & taxes is -$27.51 million

EBITDA

-$22.12M
MRAI annual EBITDA is -$22.12 million

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Total assets

$31.68M
MRAI annual total assets is $31.68 million

Non current assets

$14.59M
MRAI annual long term assets is $14.59 million

Current assets

$17.08M
MRAI annual total current assets is $17.08 million

Cash and cash equivalents

$1.15M
MRAI annual cash & cash equivalents is $1.15 million

Accounts receivable

$1.13M
MRAI annual accounts receivable is $1.13 million

Inventory

-
MRAI annual inventory value is unknown

Liabilities

Total liabilities

$45.12M
MRAI annual total liabilities is $45.12 million

Long term liabilities

$24.27M
MRAI annual total long term liabilities is $24.27 million

Current liabilities

$20.84M
MRAI annual total current liabilities is $20.84 million

Accounts payable

$4.65M
MRAI annual accounts payable is $4.65 million

Debt

Total debt

$4.20M
MRAI annual total debt is $4.20 million

Total debt 1-year change

-31.02%
MRAI annual total debt is down -31.02% year-on-year

Long term debt

$3.68M
MRAI annual long term debt is $3.68 million

Short term debt

$512.40K
MRAI annual short term debt is $512.40 thousand

Equity & Capital

Shareholders equity

-$13.44M
MRAI annual stockholders equity is -$13.44 million

Book value

-$13.44M
MRAI annual book value is -$13.44 million

Retained earnings

-$76.75M
MRAI annual retained earnings is -$76.75 million

Working capital

-$3.76M
MRAI annual working capital is -$3.76 million

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Cash from operations

-$15.75M
MRAI annual cash flow from operations is -$15.75 million

Cash from operations 1-year change

+55.31%
MRAI annual cash flow from operations is up +55.31% year-on-year

Cash from investing

$1.03M
MRAI annual cash flow from investing activities is $1.03 million

Cash from investing 1-year change

-96.83%
MRAI annual cash flow from investing activities is down -96.83% year-on-year

Cash from financing

$5.10M
MRAI annual cash flow from financing activities is $5.10 million

Cash from financing 1-year change

+2548200%
MRAI annual cash flow from financing activities is up +2548200% year-on-year

CAPEX

CAPEX

-
MRAI annual capital expenditures value is unknown

CAPEX 1-year change

-
MRAI annual capital expenditures 1-year change is unknown

Free Cash Flow

Free cash flow

-$15.75M
MRAI annual free cash flow is -$15.75 million

Free cash flow 1-year change

+56.5%
MRAI annual free cash flow is up +56.5% year-on-year

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

Gross margin

34.76%
MRAI annual gross profit margin is 34.76%

Operating margin

-70.98%
MRAI annual operating profit margin is -70.98%

Net margin

-77.38%
MRAI annual net profit margin is -77.38%

ROA & ROE

ROA

-70.45%
MRAI annual return on assets is -70.45%

ROE

213.95%
MRAI annual return on equity is 213.95%

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE ratio

-
MRAI price to earnings ratio value is unknown

PE ratio Sector rank

-
MRAI price to earnings ratio is unknown

PB Ratio

PB ratio

-0.68
MRAI price to book ratio is -0.68

PB ratio Sector rank

9.88%
MRAI price to book ratio is higher than 9.88% of companies in Healthcare sector

PS Ratio

PS ratio

0.28
MRAI price to sales ratio is 0.28

PS ratio Sector rank

9.74%
MRAI price to sales ratio is higher than 9.74% of companies in Healthcare sector

Enterprise value

Enterprise value

$13.02M
MRAI enterprise value is $13.02 million

Enterprise value Sector rank

27.79%
MRAI enterprise value is higher than 27.79% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

-0.73
MRAI EV/EBITDA is -0.73

EV/EBITDA Sector rank

47.08%
MRAI EV/EBITDA is higher than 47.08% of companies in Healthcare sector

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Current ratio

0.82
MRAI annual current ratio is 0.82

Quick ratio

-
MRAI annual quick ratio value is unknown

Leverage

Debt to equity

0.00
MRAI annual debt to equity ratio is 0.00

Interest coverage ratio

-18.01
MRAI annual interest coverage ratio is -18.01

Risk & Stability

Piotroski F-Score

4
MRAI piotroski f-score is 4

Altman Z-Score

-5.10
MRAI altman z-score is -5.10

Analyst ratings

Recent major analysts updates

Mar 28, 24 Maxim Group
Buy
Nov 15, 23 Maxim Group
Hold
Nov 14, 23 Maxim Group
Hold
Aug 1, 22 Maxim Group
Buy

Institutional Ownership

Similar stocks

IMRN logo
Immuron Limited (IMRN)
Kindly MD (KDLY)
RLMD logo
Relmada Therapeutics (RLMD)
IBIO logo
iBio (IBIO)
BTAI logo
BioXcel Therapeutics (BTAI)
XTLB logo
XTL Biopharmaceuticals (XTLB)
BSGM logo
BioSig Technologies (BSGM)
ERNA logo
Eterna Therapeutics (ERNA)
TRAW logo
Traws Pharma (TRAW)
  • What is the ticker symbol for Marpai?
  • Does Marpai pay dividends?
  • What sector is Marpai in?
  • What industry is Marpai in?
  • What country is Marpai based in?
  • When did Marpai go public?
  • Is Marpai in the S&P 500?
  • Is Marpai in the NASDAQ 100?
  • Is Marpai in the Dow Jones?
  • When was Marpai's last earnings report?
  • When does Marpai report earnings?
  • Should I buy Marpai stock now?

What is the ticker symbol for Marpai?

The ticker symbol for Marpai is NASDAQ:MRAI

Does Marpai pay dividends?

No, Marpai does not pay dividends

What sector is Marpai in?

Marpai is in the Healthcare sector

What industry is Marpai in?

Marpai is in the Healthcare Plans industry

What country is Marpai based in?

Marpai is headquartered in United States

When did Marpai go public?

Marpai's initial public offering (IPO) was on October 27, 2021

Is Marpai in the S&P 500?

No, Marpai is not included in the S&P 500 index

Is Marpai in the NASDAQ 100?

No, Marpai is not included in the NASDAQ 100 index

Is Marpai in the Dow Jones?

No, Marpai is not included in the Dow Jones index

When was Marpai's last earnings report?

Marpai's most recent earnings report was on Mar 31, 2023

When does Marpai report earnings?

The date for Marpai's next earnings report has not been announced yet

Should I buy Marpai stock now?

As of today, analysts generally recommend a 'Buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions
On this page